Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study

BACKGROUND: Pulmonary arterial hypertension (PAH)—a progressive, ultimately fatal disease—patients often experience dyspnea, which can limit their daily physical activities. Iloprost is an inhaled therapy for PAH that has shown efficacy in clinical trials. However, clinical trials in PAH have provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Christian, Stollfuss, Barbara, Roitenberg, Alexander, Harder, Jonas, Richter, Manuel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487342/
https://www.ncbi.nlm.nih.gov/pubmed/30985279
http://dx.doi.org/10.2196/12144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487342/
https://www.ncbi.nlm.nih.gov/pubmed/30985279
http://dx.doi.org/10.2196/12144

Ejemplares similares